MediciNova Statistics

Total Valuation

MediciNova has a market cap or net worth of $71.61 million. The enterprise value is $31.16 million.

Market Cap	71.61M
Enterprise Value	31.16M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

MediciNova has 49.05 million shares outstanding.

Current Share Class	49.05M
Shares Outstanding	49.05M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.98%
Owned by Institutions (%)	10.69%
Float	42.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.35
P/TBV Ratio	1.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.88, with a Debt / Equity ratio of 0.01.

Current Ratio	13.88
Quick Ratio	13.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -19.24% and return on invested capital (ROIC) is -13.67%.

Return on Equity (ROE)	-19.24%
Return on Assets (ROA)	-12.97%
Return on Invested Capital (ROIC)	-13.67%
Return on Capital Employed (ROCE)	-23.95%
Revenue Per Employee	n/a
Profits Per Employee	-$849,965
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MediciNova has paid $5,537 in taxes.

Income Tax	5,537
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.03% in the last 52 weeks. The beta is 0.73, so MediciNova's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+1.03%
50-Day Moving Average	1.72
200-Day Moving Average	1.71
Relative Strength Index (RSI)	37.89
Average Volume (20 Days)	12,398

Short Selling Information

The latest short interest is 241,334, so 0.49% of the outstanding shares have been sold short.

Short Interest	241,334
Short Previous Month	273,355
Short % of Shares Out	0.49%
Short % of Float	0.57%
Short Ratio (days to cover)	12.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.68M
Pretax Income	-8.16M
Net Income	-11.05M
EBITDA	-12.65M
EBIT	-12.68M
Earnings Per Share (EPS)	-$0.23

Full Income Statement

Balance Sheet

The company has $40.36 million in cash and $405,229 in debt, giving a net cash position of $39.95 million or $0.81 per share.

Cash & Cash Equivalents	40.36M
Total Debt	405,229
Net Cash	39.95M
Net Cash Per Share	$0.81
Equity (Book Value)	52.50M
Book Value Per Share	1.07
Working Capital	38.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.64 million and capital expenditures -$895, giving a free cash flow of -$10.64 million.

Operating Cash Flow	-10.64M
Capital Expenditures	-895
Free Cash Flow	-10.64M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MediciNova does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-15.54%
FCF Yield	-14.97%

Analyst Forecast

The average price target for MediciNova is $9.00, which is 516.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	516.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.94%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1